Your browser is out of date

With an updated browser, you will have a better Medtronic website experience.

×

Skip to main content
Alert Indications, Safety, and Warnings

Vanta™ SCS Neurostimulator  Non-rechargeable Spinal Cord Stimulation

Vanta™ SCS gives you an advantage over pain. This revolutionary non-rechargeable device offers optimized longevity, DTM™ SCS endurance programming, and unmatched MRI access.

Close-up product image of the Vanta PC Neurostimulator on white background
Alert Indications, Safety, and Warnings

Overview




Your advantage
over pain

Learn about Vanta™ SCS.

Download brochure (opens new window)

Product details

High-performance recharge-free neurostimulator



Vanta™ SCS is a high-performance recharge-free device offering optimized longevity.

  • Approximately 2x longer lasting than other devices at comparable settings*†
  • 5½–7½ years of recharge-free longevity estimated using actual 12-month DTM™ SCS endurance therapy programming data1
Vanta Platform

Product specifications

Compatible with:

  • MyStim™ PC smart patient therapy app model A72200
  • Clinician programmer model CT900 with software app A71200 and trialing app A71300
  • 16-electrode Specify™ SureScan™ MRI surgical leads
  • Vectris™ SureScan™ MRI percutaneous leads
  • INJEX™ anchoring system models 97791 and 97792

Model specifications

Model 977006 
Channels 2
Width 1.1 cm (.44in) 
Battery Type Recharge-free 

Clinical evidence for DTM™ SCS endurance therapy2:

Meaningful pain reduction

↓4.6

cm reduction in VAS for overall
pain from baseline to 12-months

Quality of life improvements

76%

of patients improved in degree
of disability at 12-months

Therapy satisfaction

86%

of patients were
satisfied with therapy at 12-months

Unmatched full-body MRI access

  • SureScan™ MRI technology allows MRI scans anywhere on the body‡ enabling diagnostic care.
  • Provide patients the same access as non-implanted patients‡ — now and in the future.
  • Shielded leads and proprietary device safeguards help patients safely get an MRI.‡
  • Access matters — 98% of patients are expected to need at least 1 MRI within 10 years of implant.3


 

Read about DTM™ SCS

Click to learn more about DTM™ SCS, a proprietary waveform supported by pre-clinical research and clinical research delivering Superior Pain Relief. Proven.1

Learn more (opens new window)

Visit Medtronic Academy

and access detailed product information, including spec sheets, videos, and presentations.

Therapy overview
SCS products
*

Settings used from Proclaim™ clinician manual. Nominal settings 12 hours per day: 50-Hz frequency. 225-μs pulse width, and 5-mA amplitude at 500-ohms impedance. Energy modeling is the same for model 3660 and model 3670.

†

Settings from Boston Scientific's Alpha™ IFU. Programmed at 4.1mA, 280us. 40Hz. 1 area, 730 Ohms, 2 contacts.

‡

Under specific conditions. Refer to product labeling for full list of conditions. Patients with non-Medtronic leads and an EMBSNV20 adaptor extension are not eligible for an MRI.

§

Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.

1

Provenzano, Amirdelfan, Grewal, et al. Modeling energy demands of a reduced-energy derivative of DTM™ stimulation on rechargeable and recharge-free SCS systems. Poster presented at: American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Pain Medicine Meeting; Nov. 17–19, 2022; Orlando, FL, USA.

2

Provenzano, Peacock, Fishman, et al. A prospective multi-center study of a reduced-energy DTM™ stimulation derivative: Long-term outcomes in therapy naïve patients. Poster presented at: American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Pain Medicine Meeting; Nov. 17–19, 2022; Orlando, FL, USA.

3

Desai MJ, Hargens LM, Breitenfeldt MD, et al. The rate of magnetic resonance imaging in patients with spinal cord stimulation. Spine. 2015;40(9):E531–537